Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$204M |
| 2 |
Peloton Interactive
PTON
|
+$199M |
| 3 |
Ecolab
ECL
|
+$185M |
| 4 |
Canadian National Railway
CNI
|
+$176M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$740M |
| 2 |
Microsoft
MSFT
|
+$500M |
| 3 |
Visa
V
|
+$424M |
| 4 |
Texas Instruments
TXN
|
+$369M |
| 5 |
Verizon
VZ
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 13.35% |
| 3 | Financials | 11.66% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
AXT Inc
AXTI
$5.18B
| $1.49M | ﹤0.01% |
168,606
+23,569
| +16% | +$199K |
|
|
BRDG
3152
DELISTED
Bridge Investment Group
BRDG
| $1.48M | ﹤0.01% |
+59,443
| New | +$1.19M |
|
3153
Stoke Therapeutics
STOK
$1.99B
| $1.48M | ﹤0.01% |
61,861
+1,924
| +3% | +$45.9K |
|
3154
Legend Biotech
LEGN
$3.91B
| $1.48M | ﹤0.01% |
+31,800
| New | +$1.61M |
|
3155
Aemetis
AMTX
$127M
| $1.48M | ﹤0.01% |
120,505
+32,246
| +37% | +$570K |
|
3156
ProShares Short S&P500
SH
$841M
| $1.48M | ﹤0.01% |
+27,163
| New | +$1.54M |
|
3157
BCB Bancorp
BCBP
$163M
| $1.48M | ﹤0.01% |
95,749
-222
| -0.2% | -$3.36K |
|
3158
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$970M
| $1.48M | ﹤0.01% |
27,289
+2,405
| +10% | +$131K |
|
3159
Cullinan Oncology
CGEM
$1.27B
| $1.47M | ﹤0.01% |
95,423
+15,259
| +19% | +$304K |
|
3160
Park-Ohio Holdings
PKOH
$705M
| $1.47M | ﹤0.01% |
69,608
+13,778
| +25% | +$312K |
|
|
BDSI
3161
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.47M | ﹤0.01% |
473,550
+83,986
| +22% | +$283K |
|
|
PVBC
3162
DELISTED
Provident Bancorp
PVBC
| $1.47M | ﹤0.01% |
78,790
-16,279
| -17% | -$293K |
|
3163
Rigel Pharmaceuticals
RIGL
$789M
| $1.46M | ﹤0.01% |
55,217
+1,015
| +2% | +$30.6K |
|
3164
Lands' End
LE
$378M
| $1.46M | ﹤0.01% |
74,302
+256
| +0.3% | +$5.95K |
|
|
BBL
3165
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1.45M | ﹤0.01% |
24,310
+2,365
| +11% | +$129K |
|
3166
Nomad Foods
NOMD
$1.66B
| $1.44M | ﹤0.01% |
56,787
-78,625
| -58% | -$2.03M |
|
3167
Accuray
ARAY
$33.6M
| $1.44M | ﹤0.01% |
301,406
-45,085
| -13% | -$217K |
|
3168
Design Therapeutics
DSGN
$924M
| $1.44M | ﹤0.01% |
67,108
+30,632
| +84% | +$526K |
|
3169
Select Water Solutions
WTTR
$2.7B
| $1.44M | ﹤0.01% |
230,665
+10,132
| +5% | +$63K |
|
|
RUBY
3170
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.44M | ﹤0.01% |
148,260
-42,349
| -22% | -$587K |
|
3171
Vanguard Industrials ETF
VIS
$8.52B
| $1.43M | ﹤0.01% |
7,057
-369
| -5% | -$73.8K |
|
|
MRNS
3172
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.43M | ﹤0.01% |
120,536
+1,639
| +1% | +$18.9K |
|
3173
American Superconductor
AMSC
$1.54B
| $1.43M | ﹤0.01% |
131,071
+1,968
| +2% | +$28.4K |
|
3174
Pure Cycle
PCYO
$272M
| $1.43M | ﹤0.01% |
97,615
-410
| -0.4% | -$6.14K |
|
|
WEBR
3175
DELISTED
Weber Inc.
WEBR
| $1.43M | ﹤0.01% |
110,262
+67,042
| +155% | +$994K |
|
Similar funds
Bank of New York Mellon's Q4 2021 Portfolio in Review
As of Q4 2021, Bank of New York Mellon held 4,753 positions worth $554B, up 8.2% from $512B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2021 filing shows 234 new, 2,052 increased, 1,966 reduced and 138 closed positions. Its largest new stake was Rivian: 608,811 shares worth $63.1M. The largest sale was Apple, an estimated $740M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2021 buy was Rivian: 608,811 shares worth $63.1M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $204M increase.
- Bank of New York Mellon's biggest Q4 2021 reduction was Apple, cutting an estimated $740M.
- Bank of New York Mellon fully exited Kansas City Southern in Q4 2021, selling an estimated $195M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $554B portfolio in Q4 2021.
- Bank of New York Mellon opened 234 new positions and closed 138 in Q4 2021.
- Bank of New York Mellon's portfolio value rose 8.2% quarter-over-quarter to $554B.
Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.